{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:32:21Z","timestamp":1776191541531,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.amjcard.2016.07.048","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T18:24:36Z","timestamp":1471199076000},"page":"1419-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation"],"prefix":"10.1016","volume":"118","author":[{"given":"Anthony P.","family":"Carnicelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"O'Gara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-7675","authenticated-orcid":false,"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.07.048_bib1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.07.048_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib3","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.110.936773","article-title":"Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface","volume":"122","author":"Achneck","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.07.048_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacc.2007.10.058","article-title":"Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications","volume":"51","author":"Russo","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM198101293040503","article-title":"Five to eight-year follow-up of patients undergoing porcine heart-valve replacement","volume":"304","author":"Cohn","year":"1981","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.048_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejcts.2007.03.031","article-title":"Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors","volume":"32","author":"Brueck","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.biomaterials.2006.09.005","article-title":"Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization","volume":"28","author":"Mercuri","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.amjcard.2016.07.048_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.RES.0000185326.04010.9f","article-title":"Heart valve tissue engineering","volume":"97","author":"Vesely","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2016.07.048_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/cd.2000.v25.a103682","article-title":"Long-term performance of heart valve prostheses","volume":"25","author":"Grunkemeier","year":"2000","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib13","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","article-title":"Intrinsic pathway of coagulation and arterial thrombosis","volume":"27","author":"Gailani","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib14","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2016.07.048_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1440-1681.2008.05099.x","article-title":"Fluid mechanics of artificial heart valves","volume":"36","author":"Dasi","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib16","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2016.07.048_bib17","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.048_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A\u00a0comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.048_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.048_bib21","doi-asserted-by":"crossref","first-page":"e002322","DOI":"10.1161\/JAHA.115.002322","article-title":"Dabigatran is less effective than warfarin at attenuating mechanical heart valve-induced thrombin generation","volume":"4","author":"Jaffer","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2016.07.048_bib22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jtcvs.2014.01.004","article-title":"Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial","volume":"147","author":"Puskas","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.113.002003","article-title":"Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"127","author":"Brennan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib24","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"Merie","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.07.048_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"60","author":"Brennan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib26","first-page":"667","article-title":"Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial","volume":"16","author":"Colli","year":"2007","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2016.07.048_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejcts.2004.12.064","article-title":"Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (TRAC): prospective, randomized, co-operative trial","volume":"27","author":"Aramendi","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jtcvs.2004.11.028","article-title":"Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?","volume":"129","author":"Sundt","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.CIR.0000137122.95108.52","article-title":"Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study","volume":"110","author":"Gherli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib30","first-page":"II95","article-title":"Anticoagulation is unnecessary after biological aortic valve replacement","volume":"98","author":"Moinuddeen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib31","first-page":"574","article-title":"Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience","volume":"7","author":"Goldsmith","year":"1998","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.amjcard.2016.07.048_bib32","first-page":"II214","article-title":"Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement","volume":"90","author":"Blair","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0003-4975(10)60717-5","article-title":"Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis","volume":"37","author":"Nunez","year":"1984","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib34","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.048_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCOUTCOMES.115.002696","article-title":"Safety and use of anticoagulation after aortic valve replacement with bioprostheses: a meta-analysis","volume":"9","author":"Riaz","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2016.07.048_bib36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.07.048_bib37","doi-asserted-by":"crossref","first-page":"A17277","DOI":"10.1161\/circ.132.suppl_3.17277","article-title":"Apixaban use in patients with atrial fibrillation with bioprosthetic valves: insights from ARISTOTLE","volume":"132","author":"Pokorney","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.048_bib38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0735-1097(16)32195-7","article-title":"Outcomes in 2824 patients with valvular heart disease treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"67","author":"Renda","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib39","series-title":"ClinicalTrials.gov [Internet]","article-title":"Comparison of antithrombotic treatments after aortic valve replacement. Rivaroxaban: a new antithrombotic treatment for patients with mechanical prosthetic aortic heart valve. (CATHAR)","year":"2014"},{"key":"10.1016\/j.amjcard.2016.07.048_bib40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2016.07.048_bib41","unstructured":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, Endorsed by the European Stroke Organization (ESO), Eur Heart J, In press."},{"key":"10.1016\/j.amjcard.2016.07.048_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejcts.2007.12.019","article-title":"ACTION Registry Investigators. Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results","volume":"33","author":"Colli","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2016.07.048_bib43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.2015.1474","article-title":"STS\/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement","volume":"313","author":"Holmes","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.07.048_bib44","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2013.03.029","article-title":"Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events","volume":"62","author":"Rodes-Cabau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.048_bib45","series-title":"ClinicalTrials.gov [Internet]","article-title":"Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation (POPular-TAVI)","year":"2014"},{"key":"10.1016\/j.amjcard.2016.07.048_bib46","series-title":"ClinicalTrials.gov [Internet]","article-title":"Platelet reactivity after TAVI: a multicenter pilot study (REAC-TAVI)","author":"Romo","year":"2014"},{"key":"10.1016\/j.amjcard.2016.07.048_bib47","series-title":"ClinicalTrials.gov [Internet]","article-title":"Inflammation and thrombosis in patients with severe aortic stenosis after transcatheter aortic valve replacement (TAVR)","author":"Zidar","year":"2015"},{"key":"10.1016\/j.amjcard.2016.07.048_bib48","series-title":"ClinicalTrials.gov [Internet]","article-title":"Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to optimize clinical outcomes (GALILEO)","year":"2015"},{"key":"10.1016\/j.amjcard.2016.07.048_bib49","series-title":"ClinicalTrials.gov [Internet]","article-title":"RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial \u2013 RIVER trial","year":"2014"},{"key":"10.1016\/j.amjcard.2016.07.048_bib50","series-title":"ClinicalTrials.gov [Internet]","article-title":"Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation (RESOLVE)","author":"Makkar","year":"2014"},{"key":"10.1016\/j.amjcard.2016.07.048_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacc.2015.06.1322","article-title":"Initial experience of transcatheter mitral valve replacement with a novel transcatheter mitral valve: procedural and 6-month follow-up results","volume":"66","author":"Abdul-Jawad Altisent","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:32:59Z","timestamp":1657063979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916313182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002914916313182"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.048","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}